amneal.com (AMRX) - Bozor qiymatining balans qiymatiga nisbati

Amneal Pharmaceuticals, Inc. (AMRX) - korporativ logo

Amneal Pharmaceuticals (AMRX) rivojlanishi murakkab biosimilarlarning tijoratlashtirish sur'atiga bog'liq bo'lib, bunda barqaror pul oqimlari mavjud bo'lishiga qaramay, narxlardagi bosim va qarzlar e'tiborni talab qiladi. Geopolitik keskinliklar va Osiyodan xomashyo yetkazib berishning buzilishi ommaviy ishlab chiqarish uchun xavf tug'diradi. GURU.Markets platformasidagi ushbu bozor baholashi, bunda ko'rsatkich 211.37 darajasida turibdi, kompaniyaning bashorat qilinadigan erkin pul oqimiga ega bo'lgan hamyonbop dori vositalari ishlab chiqaruvchisi sifatidagi maqomini tasdiqlaydi.

Amneal Corp (AMRX) - Balans qiymatiga nisbatan bozor qiymati 04.07.2022dan 30.10.2026gacha

Amneal Pharmaceuticals, Inc. (AMRX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Aksiya kotirovkalari Amneal Pharmaceuticals|AMRX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Amneal Pharmaceuticals Inc|AMRX - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Amneal Pharmaceuticals|AMRX - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati amneal.com|AMRX - Kompaniyaning umumiy aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Amneal Pharmaceuticals|AMRX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Amneal Pharmaceuticals Inc|AMRX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Amneal Pharmaceuticals Inc|AMRX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Amneal Pharmaceuticals|Tezkor likvidlik amneal.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
AMRX - Kompaniyaning sof daromadi
Kompaniyaning asosiy tahlili:Amneal Pharmaceuticals - AMRX
Amneal Pharmaceuticals Inc ishlab chiqargan mahsulot

Ushbu ko'rsatkich biznesning haqiqiy kapitaliga nisbatan haddan tashqari qimmat baholanganlik darajasini aniqlash uchun aksiyalarning bozor qiymatini kompaniyaning sof aktivlari bilan solishtiradi. Joriy narxning buki ko'rsatkichini tahlil qilish Amneal Pharmaceuticals (AMRX) barqarorligini baholash imkonini beradi, uning yopiq generiklar ekotizimi va B2B hamkorlarining sodiqligi marjaga nisbatan tartibga soluvchi o'zgarishlar bosimi ostida ham ishonchli poydevor yaratadi.

Raqobatchilar tahlili

HLN (Haleon plc) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati KVUE|Bozor qiymatining balans qiymatiga nisbati Verona Pharma|Jyong Biotech Limited - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati LGND|PRGO (Perrigo Corp) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ALVO (Alvotech)|Bozor kapitallashuvining balans qiymatiga nisbati liquidia.com LQDA|GLPG - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ANIP (ANI Pharmaceuticals Inc)|MannKind Corp. (MNKD) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Amphastar Corp|PCRX (Pacira BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com|Kapitallashuvning sof aktivlarga nisbati TBPH (Theravance Biopharma, Inc.)|AQST (Aquestive Therapeutics Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati scPharmaceuticals SCPH|Tectonic Therapeutic Inc. (TECX) - Bozor qiymatining balans qiymatiga koeffitsiyenti|TNXP: Kapitallashuvning sof aktivlarga nisbati|China SXT Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga multiplikatori|EPRX: Bozor kapitallashuvining balans qiymatiga nisbati|BioHarvest Sciences, Inc. - Balans qiymatiga nisbatan bozor qiymati|EXOZ (Invizyne Technologies, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Oramed Pharma ORMP|Bozor qiymatining balans qiymatiga nisbati Entera Bio Ltd. (ENTX)|HYFT (ipatherapeutics.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ABVC (ABVC BioPharma, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati Cumberland Pharmaceuticals Inc CPIX|QNTM - Bozor qiymatining balans qiymatiga nisbati|FibroGen Corporation (FGEN) - Kapitallashuvning sof aktivlarga nisbati|Telomir Pharmaceuticals (TELO) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RANI|SNYR (Synergy CHC Corp.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Rallybio Corp. RLYB|Bozor kapitallashuvining balans qiymatiga nisbati LEXX|Bozor kapitallashuvining balans qiymatiga nisbati Pulmatrix Corporation (PULM)|Bozor qiymatining balans qiymatiga nisbati Pheton Holdings PTHL|Aptorum Group Ltd - Bozor qiymatining balans qiymatiga nisbati|LYRA: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati IBO (impactbiomedinc.com)|tnfpharma.com (TNFA) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi YCBD (cbdMD)|PRFX (PainReform Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|CYTO: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati LIPO|Bozor kapitallashuvining balans qiymatiga nisbati OptiNose Inc (OPTN)|Bozor qiymatining balans qiymatiga nisbati Pieris PIRS|Balans qiymatiga nisbatan bozor qiymati PROC|PTPI - Bozor qiymatining balans qiymatiga nisbati|qlsyy.net (QLI) - Kapitallashuvning sof aktivlarga nisbati|SLRN: Bozor kapitallashuvining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Bozor kapitallashuvining balans qiymatiga nisbati